128 related articles for article (PubMed ID: 30698092)
1. Modeling Episode-Based Payments for Cancer Using Commercial Claims Data.
Polson M; Lord T; Evangelatos T; Kangethe A; Speicher LC; Barrientos S; Zacker C
J Manag Care Spec Pharm; 2019 Feb; 25(2):235-245. PubMed ID: 30698092
[TBL] [Abstract][Full Text] [Related]
2. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
3. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
4. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M
J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388
[TBL] [Abstract][Full Text] [Related]
5. Assessing Medicare's Approach To Covering New Drugs In Bundled Payments For Oncology.
Muldoon LD; Pelizzari PM; Lang KA; Vandigo J; Pyenson BS
Health Aff (Millwood); 2018 May; 37(5):743-750. PubMed ID: 29733731
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
7. What Factors are Associated With 90-day Episode-of-care Payments for Younger Patients With Total Joint Arthroplasty?
Pathak S; Ganduglia CM; Awad SS; Chan W; Swint JM; Morgan RO
Clin Orthop Relat Res; 2017 Nov; 475(11):2808-2818. PubMed ID: 28707110
[TBL] [Abstract][Full Text] [Related]
8. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
9. Episode-Based Payment for the Medicare Outpatient Therapy Benefit.
Amico P; Pope GC; Meadow A; West P
Arch Phys Med Rehabil; 2016 Aug; 97(8):1323-8. PubMed ID: 27060033
[TBL] [Abstract][Full Text] [Related]
10. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
[TBL] [Abstract][Full Text] [Related]
11. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
[TBL] [Abstract][Full Text] [Related]
12. Bundled Payment Models for Actinic Keratosis Management.
Kirby JS; Delikat A; Leslie D; Miller JJ
JAMA Dermatol; 2016 Jul; 152(7):789-97. PubMed ID: 27028662
[TBL] [Abstract][Full Text] [Related]
13. Implications of the Definition of an Episode of Care Used in the Comprehensive Care for Joint Replacement Model.
Ellimoottil C; Ryan AM; Hou H; Dupree JM; Hallstrom B; Miller DC
JAMA Surg; 2017 Jan; 152(1):49-54. PubMed ID: 27682525
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study.
Yang J; Chaudhry BI; Yue AT; Roth JA; Kelton JM; Shelbaya A; Tran L; Li M
Adv Ther; 2024 Jan; 41(1):349-363. PubMed ID: 37957523
[TBL] [Abstract][Full Text] [Related]
15. Design Challenges of an Episode-Based Payment Model in Oncology: The Centers for Medicare & Medicaid Services Oncology Care Model.
Kline RM; Muldoon LD; Schumacher HK; Strawbridge LM; York AW; Mortimer LK; Falb AF; Cox KJ; Bazell C; Lukens EW; Kapp MC; Rajkumar R; Bassano A; Conway PH
J Oncol Pract; 2017 Jul; 13(7):e632-e645. PubMed ID: 28535101
[TBL] [Abstract][Full Text] [Related]
16. What Drives Variation in Episode-of-care Payments for Primary TKA? An Analysis of Medicare Administrative Data.
Cram P; Ravi B; Vaughan-Sarrazin MS; Lu X; Li Y; Hawker G
Clin Orthop Relat Res; 2015 Nov; 473(11):3337-47. PubMed ID: 26239239
[TBL] [Abstract][Full Text] [Related]
17. Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment.
Duwayri YM; Aiello FA; Tracci MC; Nedza S; Ryan PC; Adams JG; Shutze WP; Lum YW; Woo K
J Vasc Surg; 2021 Feb; 73(2):662-673.e3. PubMed ID: 32652115
[TBL] [Abstract][Full Text] [Related]
18. Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes.
Rosen AB; Aizcorbe A; Ryu AJ; Nestoriak N; Cutler DM; Chernew ME
Health Aff (Millwood); 2013 May; 32(5):944-51. PubMed ID: 23650329
[TBL] [Abstract][Full Text] [Related]
19. An Empirical Framework for Breast Screening Bundled Payments.
Hughes DR; Jiang M; McGinty G; Shetty SK; Duszak R
J Am Coll Radiol; 2017 Jan; 14(1):17-23.e1. PubMed ID: 27544355
[TBL] [Abstract][Full Text] [Related]
20. Association Between Postoperative Pneumonia and 90-Day Episode Payments and Outcomes Among Medicare Beneficiaries Undergoing Cardiac Surgery.
Thompson MP; Cabrera L; Strobel RJ; Harrington SD; Zhang M; Wu X; Prager RL; Likosky DS
Circ Cardiovasc Qual Outcomes; 2018 Sep; 11(9):e004818. PubMed ID: 30354549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
